sitosterolemia 1
MONDO:0020747
Any sitosterolemia caused by a variation in the ABCG8 gene, characterized by increased intestinal absorption and reduced biliary excretion of plant sterols, leading to markedly elevated plasma sitosterol and related phytosterols, xanthomas, and premature atherosclerosis/coronary disease. Some patients develop hematologic manifestations, including stomatocytic hemolysis, macrothrombocytopenia, splenomegaly, and abnormal bleeding. In some cases the hematologic phenotype can be the presenting or only sign. Biallelic loss‑of‑function variants in ABCG8 impair the heterodimeric transporter that normally limits sterol absorption and promotes biliary sterol excretion, explaining the biochemical and clinical findings.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.